T89

DRUG2 trials

Sponsors

Tasly Pharmaceuticals, Inc.

Conditions

Angina PectorisCoronavirus Disease 2019Novel Coronavirus Pneumonia

Phase 2

Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina

CompletedNCT00797953

Tasly Pharmaceuticals, Inc.Angina Pectoris

Start: 2007-02-28End: 2010-01-31Updated: 2012-12-12

Unknown Phase

The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19

WithdrawnNCT04285190

Tasly Pharmaceuticals, Inc.Coronavirus Disease 2019, Novel Coronavirus Pneumonia

Start: 2020-02-26End: 2020-04-20Updated: 2020-06-16